Use of antihypertensive drugs by Medicare enrollees: Does type of drug coverage matter?
Use of antihypertensive drugs by Medicare enrollees: Does type of drug coverage matter?
复制标题
DOI：
10.1377/hlthaff.20.1.276
复制
发表时间：
2001-01-01
期刊：
影响因子：
9.7
通讯作者：
Ross-Degnan, D
中科院分区：
文献类型：
--
作者：
Adams, AS;Soumerai, SB;Ross-Degnan, D
研究表明，有药品保险的医疗保险受益人消耗更多的临床基本药物。然而，不同受益人的保险范围差别很大。本研究探讨了高血压受益人中药物覆盖类型与每片基本抗高血压药物的消费和成本之间的关系。研究结果表明，虽然国家和雇主赞助的药物覆盖范围与抗高血压药物的消费量增加和每片自付费用降低有关，但私人补充覆盖范围与更多的使用无关，并且仅与略低的自付费用有关。
Research has demonstrated that Medicare beneficiaries with drug coverage consume more clinically essential drugs. However, generosity of coverage varies considerably across beneficiaries. This study examines the association between types of drug coverage and the consumption and cost per tablet of essential antihypertensive medications among beneficiaries with hypertension. The findings indicate that while both state- and employer-sponsored drug coverage are associated with greater consumption of antihypertensive drugs and lower out-of-pocket costs per tablet, private supplemental coverage is not associated with greater use and is associated with only slightly lower out-of-pocket costs than among noncovered beneficiaries.